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Abstract
Introduction: Most human mammary epithelial cells (HMEC) cultured from histologically normal breast tissues
enter a senescent state termed stasis after 5 to 20 population doublings. These senescent cells display increased
size, contain senescence associated b-galactosidase activity, and express cyclin-dependent kinase inhibitor, p16
INK4A
(CDKN2A; p16). However, HMEC grown in a serum-free medium, spontaneously yield, at low frequency, variant (v)
HMEC that are capable of long-term growth and are susceptible to genomic instability. We investigated whether
ionizing radiation, which increases breast cancer risk in women, affects the rate of vHMEC outgrowth.
Methods: Pre-stasis HMEC cultures were exposed to 5 to 200 cGy of sparsely (X- or g-rays) or densely (1 GeV/amu
56Fe)
ionizing radiation. Proliferation (bromodeoxyuridine incorporation), senescence (senescence-associated b-galactosidase
activity), and p16 expression were assayed in subcultured irradiated or unirradiated populations four to six weeks
following radiation exposure, when patches of vHMEC became apparent. Long-term growth potential and p16
promoter methylation in subsequent passages were also monitored. Agent-based modeling, incorporating a simple set
of rules and underlying assumptions, was used to simulate vHMEC outgrowth and evaluate mechanistic hypotheses.
Results: Cultures derived from irradiated cells contained significantly more vHMEC, lacking senescence associated
b-galactosidase or p16 expression, than cultures derived from unirradiated cells. As expected, post-stasis vHMEC
cultures derived from both unirradiated and irradiated cells exhibited more extensive methylation of the p16 gene
than pre-stasis HMEC cultures. However, the extent of methylation of individual CpG sites in vHMEC samples did
not correlate with passage number or treatment. Exposure to sparsely or densely ionizing radiation elicited similar
increases in the numbers of vHMEC compared to unirradiated controls. Agent-based modeling indicated that
radiation-induced premature senescence of normal HMEC most likely accelerated vHMEC outgrowth through
alleviation of spatial constraints. Subsequent experiments using defined co-cultures of vHMEC and senescent cells
supported this mechanism.
Conclusions: Our studies indicate that ionizing radiation can promote the outgrowth of epigenetically altered cells
with pre-malignant potential.
Introduction
Carcinogenic consequences of radiation exposure have
historically been attributed to targeted effects - misre-
paired DNA damage directly caused by dose-dependent
ionization events in the cell of cancer origin. Radiation can
also induce non-targeted effects - altered cytokines and
signaling that affect the cellular composition and microen-
vironment of irradiated tissues [1], and non-mutational,
but heritable changes that alter cell-cell interactions and
induce persistent phenotypes associated with malignant
progression [2-4]. The potential carcinogenic contribution
of these non-targeted effects, which are typically not line-
arly proportional to radiation dose, has not been well stu-
died, particularly in primary human epithelial cells.
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mammary epithelial cells (HMEC) as an experimental
system to directly evaluate the potential of ionizing
radiation to promote the outgrowth of cells bearing a
pre-malignancy-associated epigenetic change. In serum-
free growth medium, HMEC from histologically normal
breast tissues arrest growth after 5 to 20 population
doublings, exhibit senescent morphologies, and express
p16
INK4A (CDKN2A; p16) [5,6]. This p16-dependent
form of senescence, termed stasis,i sd i s t i n g u i s h e db y
irreversible growth arrest with 2N DNA content
(reviewed in [7]). Stasis is associated with poorly defined
imbalances in signal transduction brought on by cell
culture conditions or oncogene activation, but is not
directly associated with DNA damage or dysfunctional
telomeres [8,9]. Stasis requires activation of another
well-known tumor suppressor, pRB, which functions
downstream of p16, and serves as a block to indefinite
proliferation (immortality) - a prerequisite for malignant
transformation. The heterogeneous p16 expression
observed in human breast epithelial cells in situ [10],
and frequent aberrations in the p16-pRB pathway in
human tumors [11], suggest that conditions that influ-
ence its expression and silencing have physiological and
pathological relevance.
HMEC cultured in a serum-free medium spontaneously
yield rare variant (vHMEC) cells in which p16 genes are
methylated and silenced at frequencies that differ among
normal specimens from women [12]. In previous studies,
such vHMEC have been shown to be susceptible to geno-
mic instability associated with telomere and centrosome
dysfunction [6,13,14]. In some cases following carcinogen
or oncogene exposure, these vHMEC give rise to immor-
talized clones bearing chromosomal aberrations com-
monly observed in primary human breast tumors [15].
Here, we sought to determine whether low to moderate
doses of radiation (5-200 cGy) would alter the rate of
vHMEC outgrowth from non-malignant tissues. In repli-
cate experiments using HMEC from four different speci-
mens, we found that radiation caused shorter growth
plateaus and significantly increased the rate at which p16
(-) vHMEC grew out in long term cultures. Computer
simulations using an agent-based model suggested that
radiation accelerated selection of pre-existing vHMEC, a
prediction that was confirmed experimentally. Thus non-
targeted radiation effects can lower a critical cancer barrier
by altering cell interactions to promote outgrowth of cells
with pre-malignant phenotypes.
Materials and methods
Cell culture
Histologically normal breast tissues, obtained from sur-
gically discarded reduction mammoplasty (B1400 and
N17) and prophylactic mastectomy (B1389 & B1450)
specimens with patients’ informed consent and institu-
tional review board approval, were provided by the
UCSF Cancer Center and the Cooperative Human Tis-
sue Network. Specimens B1400 and N17 were derived
from disease-free women aged 50 and 17 years, respec-
tively. Specimen B1389 was derived from a 53-year old
woman with a family history of breast and ovarian can-
cer, diagnosed with non-proliferative fibrocystic disease.
Specimen B1450 was derived from a woman of unspeci-
fied age, diagnosed with invasive ductal and lobular car-
cinoma in the contralateral breast. Tissue samples were
minced and enzymatically dissociated using 0.1% w/v
collagenase I in Dulbecco’s Modified Eagle Medium at
37°C for 12 to 18 hrs. Small tissue fragments (organoids)
remaining after digestion, were collected by centrifuga-
tion at 100 × g for two minutes. These organoids were
stored frozen or seeded directly into Mammary Epithe-
lial Cell Growth Medium (MEGM; Lonza, Walkersville,
MD, USA). The resulting HMEC were cultured in
serum-free MEGM medium as previously described [16]
and verified to be mycoplasma-free (Bionique Testing
Laboratories (Saranac Lake, NY, USA). HMEC were
routinely subcultured when 80% confluent and reseeded
at a densities of 5 × 10
3 cells/cm
2. Total population
doublings were estimated using the equation, Population
Doublings (PD) = log (A/B)/log2, where A was the num-
ber of collected cells and B was the number of plated
cells. The effects of plating efficiencies were not taken
into account in these estimates, and the calculated
values were therefore lower than actual values. In some
experiments, 5-aza-2’-deoxycytidine was added at a con-
centration of 3.3 μM to the culture medium for 72 to
96 hours prior to harvest.
Experimental design
Passage 4 HMEC were routinely seeded at a density of
0.25 × 10
6 cells per T-25 flask. The cells were grown for
seven to eight days to 60% confluence prior to radiation
exposure. Control plates were sham-irradiated. After
irradiation, the cells were allowed to recover for 48 hrs,
then dissociated with trypsin and replated at densities of
0.25 × 10
6 cells per 100 mm dish. The cultures were
then incubated for four to six weeks. When visual
inspection indicated that the largest patches of vHMEC
had attained diameters of 1.3 to 2.5 cm, all the cultures
were harvested for analysis. To generate growth curves,
both irradiated and unirradiated HMEC cultures were
maintained in triplicate through Passage 9.
Irradiation
Low linear energy transfer (LET) exposures were con-
ducted using either 160 kVp X-ray or
137Cs g-irradia-
tion. Cultures were exposed to single doses of 5, 25, 50,
100 or 200 cGy at dose rates of either 22.5 cGy/minute
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High-LET radiation exposures were conducted using a 1
GeV/amu
56Fe ion source at the NASA Space Radiation
Laboratory at Brookhaven National Laboratory (Upton,
NY, USA).
Senescence associated b-galactosidase (SA-bgal) activity
For visualization, cells were washed, fixed, and incubated
overnight at 37°C with X-gal chromogenic substrate at
pH 6.0 as described [17]. The cells were viewed and
photographed using a phase contrast Nikon Eclipse
TS100 microscope (Nikon Instruments Inc., Melville,
NY, USA). For quantitation of SA-bgal (+) and (-) cells
by flow cytometry, fluorescein digalactoside (FDG;
Molecular Probes, Eugene, OR, USA) was used as a sub-
strate as described [18-20]. Cells were dissociated and
resuspended in phosphate buffer saline containing 5%
fetal bovine serum (PBS/FBS). Diluted FDG solution was
mixed with an equal volume of cell suspension, incu-
bated at room temperature for three minutes and
quenched by adding 10 volumes of PBS/FBS. Propidium
iodide (1.25 μg/ml, Molecular Probes, Eugene, OR,
USA) was added to exclude dead cells from analysis.
Flow cytometry was performed using a FACScan flow
cytometer and Cell Quest Pro software (Becton Dickin-
son, Franklin Lakes, NJ, USA). Determinations of the
relative sensitivities of HMEC and vHMEC to radiation-
induced senescence were estimated using the formula:
PD P
P
ss
s
() − ()
− ()
0
10
, in which Ps(0) and Ps(D) were the
respective percentages of SA-bgal(+) cells in a popula-
tion before and after exposure to a radiation dose (D).
The formula included the factor 1-Ps(0) to correct for
SA-bgal(+) cells pre-existing in the population.
p16 immunohistochemistry and immunofluorescence
Cells were fixed with 4% paraformaldehyde for 30 min-
utes, washed and permeabilized with 0.1% Triton: 3%
H2O2 for five minutes, incubated with a 1:300 dilution
of primary antibodies (JC2, Neomarkers, Fremont, CA,
USA), and washed three to four times. For visualization,
the cells were incubated with VectaStain ABC reagent,
followed by DAB substrate (Vector Laboratories, Burlin-
game, CA, USA). For quantitation, the cells were incu-
bated with Alexa Fluor 488 conjugated goat anti-mouse
IgG (1:200) secondary antibodies. Nuclei were counter-
stained with 0.5 ng/ml 4,6-diamidino-2-phenylindole
(DAPI; Molecular Probes, Eugene, OR, USA). Images for
individual channels were acquired and quantitated using
a Cellomics Array Scan V
TI (Thermo Scientific, Pitts-
burgh, PA, USA), and merged using Adobe Photoshop
6.0 software (Adobe Systems, San Jose, CA, USA).
DNA synthesis
Cells were incubated for the final 24 hr prior to harvest
with 10 μM bromodeoxyuridine (BrdU; BD Biosciences,
San Jose, CA, USA), then dissociated, washed with med-
ium containing 2% FCS, and fixed with 95% ethanol.
Nuclei were prepared by incubating the fixed cells with
0.8% pepsin for 20 minutes at 37°C, followed by an IFA
buffer (10 mM HEPES, 150 mM NaCl, 4% FBS, and
0.1% sodium azide) wash containing 0.5% Tween. The
nuclei were then incubated with a 1:5 dilution of fluor-
oscein-conjugated anti-BrdU antibodies in IFA (BD
Biosciences, San Jose, CA, USA) on ice for 30 minutes,
followed by treatment with RNase A (5 μg/ml) and pro-
pidium iodide (5 μg/ml). Flow cytometry was performed
as described above.
Bisulfite sequencing
Genomic DNA was isolated from cells using the Wizard
Genomic DNA Isolation kit (Promega, Madison, WI,
USA). A total of 500 to 1,000 ng of DNA was treated
with bisulfite using the EZ DNA Methylation-Gold kit
(Zymo Research, Orange, CA, USA). Polymerase chain
reaction amplification of the p16 gene promoter region
was performed using the primer set 5’ TTT TTA GAG
GAT TTG AGG GAT AGG 3’ (-159 to -136) and 5’
CTA CCT AAT TCC AAT TCC CCT ACA 3’ (+209 to
+233) [21,22] and the following conditions: 95°C/two
minutes × one cycle; 96°C/20 sec, 60°C/20 sec and 72°
C/90 sec × 40 cycles; 72°C/five minutes × one cycle.
PCR products were purified with the QIAquick gel
extraction kit (Qiagen, Valencia, CA, USA) and cloned
in the pGEMT vector (Promega, Madison, WI, USA).
Individual clones were sequenced with M13 forward
and/or reverse primers.
Immunoblot analyses
Total cell lysates were prepared in SDS/Tris buffer with
protease inhibitors (Complete, Roche Applied Science,
Indianapolis, IN, USA) and 20 to 30 μg/lane were sepa-
rated on gradient SDS-PAGE gels (Invitrogen). After
transfer, the separated proteins were incubated with a
1:1000 dilution of p16 antibodies (JC2, Neomarkers), fol-
lowed by imaging using an Odyssey infrared imaging
system (Licor Biosciences, Lincoln, Nebraska, USA).
Statistical analyses
Graphpad Prism 5 (GraphPad Software, Inc., La Jolla,
CA, USA) and JMP IN 3 (JMP, Cary, NC, USA) soft-
ware were used for all the statistical analyses.
Agent-based modeling
Simulations were performed using Matlab software (The
MathWorks, Natick, MA, USA). Agents were dispersed
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grid (1.5 mm/pixel) at initial densities of 1,200 agents/
grid (20% confluence). The following rules were used
for modeling the growth of HMEC: 1) agents could
divide as long as there was open space surrounding
them; 2) if there was no more open space, agents could
still divide but would be compressed until they reached a
minimum size; 3) when an agent had reached the maxi-
mum number of divisions allowed, it would stop divid-
ing and its type changed permanently to a senescent
type; 4) senescent agents could not reattach after
detachment during subculture. The program was reini-
tiated using the resulting agents when the grid reached
80% saturation (approximately 6,000 agents/grid) to
simulate re-plating. For each set of experimental condi-
tions, five independent simulations were performed,
leading to an average behavior with a relative standard
error less than 10%. By representing the grid as a tensor
whose vectors are properties of the included agents, the
progression of the tensor could be visualized using the
advanced imaging platform DIPimage (Image Processing
Toolbox for Matlab, Delft University of Technology,
Delft, The Netherlands). A growth plateau was defined
as the period during which the rate of population dou-
bling deviated significantly from an exponential rate.
Plateau width was determined experimentally as the
time to 80% confluence of HMEC cultures in which the
majority of cells displayed morphological features of
senescence immediately after plating.
Results
The progeny of HMEC exposed to a moderate radiation
dose form larger, more numerous patches of SA-bgal (-)
and p16 (-) cells
We cultured primary HMEC from four histologically
normal breast tissue specimens and grew them in
serum-free MEGM medium under standard adherent
conditions [5], subdividing and passaging them before
they achieved confluence. At the fourth passage (4p) fol-
lowing establishment in culture, replicate HMEC cul-
t u r e sw e r ee x p o s e dt oas i n g l ed o s eo fX - r a y s( 0o r2 0 0
cGy). The cells were then re-fed with complete growth
medium and allowed to recover for two to four days
prior to re-plating at identical cell densities, before con-
trol cultures reached confluence. Although the kinetics
differed among specimens (B1450, B1400 and B1389),
the irradiated cultures ultimately grew faster and under-
went more population doublings than the unirradiated
cultures in all cases (Figure 1A).
Soluble factors induced by ionizing radiation, such as
TGFb, affect the growth of unirradiated cells [2]. To
determine whether the effect of radiation observed on
the outgrowth of surviving cells was due to secreted
f a c t o r s ,c o n d i t i o n e dm e d i u mf r o mi r r a d i a t e do ru n i r r a -
diated cultures was added to the growth medium of uni-
rradiated cultures. One set of irradiated and three sets
of unirradiated B1400 or B1450 cultures were main-
tained separately. One unirradiated set served as a con-
trol and received only fresh medium at each feeding. A
second unirradiated set received a 1:1 mixture of condi-
tioned medium from irradiated cultures and fresh med-
ium, while a third unirradiated set received a 1:1
mixture of conditioned medium from unirradiated cul-
tures and fresh medium. Four replicates for each culture
condition were maintained in this manner for four to
six weeks. We did not observe any significant differences
in the outgrowth of vHMEC in cultures supplemented
with conditioned medium from irradiated or unirra-
diated cultures (data not shown). Thus soluble factors
were not a likely cause of the differences observed.
We examined unirradiated and irradiated cultures 48
hrs following irradiation at 4p. The cultures exhibited
similar cell densities and morphologies; areas of small
proliferative cells were interspersed with large, flat non-
mitotic cells in both (Figure 1B, upper panels). However,
four to six weeks after irradiation, large uniform patches
of small proliferative cells were evident earlier and were
more numerous in the subcultured (5p) irradiated popu-
lations than in the unirradiated populations (Figure 1B,
lower panels, and Figure 1C).
The expression of SA-bgal activity [17], a marker of
cellular senescence, was measured in unirradiated and
irradiated cultures when patches of vHMEC in unirra-
diated cultures reached 1.2 to 1.7 cm in diameter, typi-
cally four to six weeks post-irradiation. SA-bgal (-) cells
were more abundant in irradiated than in the unirra-
diated cultures at these times (Figure 2A). To determine
whether the differences observed between the percen-
tages of SA-bgal (-) and (+) cells in irradiated and uni-
rradiated cultures were statistically significant, 10
irradiated replicate cultures and 10 control replicate cul-
tures from specimen B1450 were tracked independently.
Flow cytometry was used to quantitate and compare the
percentage of SA-bgal (-) cells in cultures four to six
weeks following irradiation. At the time of harvest, 85.2
± 1.6% of the cells in the irradiated cultures were SA-
bgal (-), whereas 78.0 ± 2.6% of the cells in the unirra-
diated cultures were SA-bgal (-) (P < 0.001) (Figure 2B).
We next measured the expression of p16 protein by
immunofluorescence in unirradiated and irradiated cul-
tures harvested at identical times (Figure 2C). More
than 20 random fields from unirradiated and irradiated
B 1 4 5 0a n dB 1 4 0 0c u l t u r e sw e r e analyzed. Significantly
more (70.5 ± 3.3% vs. 44.8 ± 3.5, P < 0.0001) cells were
p16 (-) in the irradiated cultures than those in the uni-
rradiated cultures (Figure 2D).
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both unirradiated and irradiated HMEC
The lack of p16 expression in unirradiated vHMEC has
been associated with methylation of the p16 gene pro-
moter, as treatment with 5-aza-2’-deoxycytidine - an
established inhibitor of DNA methylation, leads to
induction of p16 expression and growth arrest in these
cells [23-25]. To determine whether a qualitatively simi-
lar or distinct mechanism of p16 gene inactivation was
responsible for the increased outgrowth of vHMEC in
irradiated cultures, we first compared the susceptibility
of irradiated and unirradiated cultures to 5-aza-2’-deox-
ycytidine-induced p16 expression. Immunoblot analyses
and immunohistochemical staining showed a general
lack of p16 protein expression in the cells that emerged
from stasis cultures, although occasional p16 (+) cells
continued to be observed in vHMEC cultures derived
from both unirradiated and irradiated cells (Figure 3A
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Figure 1 The growth of human mammary epithelial cells cultures exposed to 200 cGy exceeds that of unirradiated cultures. (A) Plots
of the total population doublings of irradiated and unirradiated human mammary epithelial cells (HMEC) cultures versus days in culture for three
experiments in which HMEC from different individuals were used (top to bottom; specimens B1450, B1400, and B1389). Each of the experimental
points plotted in the graphs represents one passage. The time of irradiation between Passages 4 and 5 is indicated with a thunderbolt symbol.
(B) Representative fields are seen in phase micrographs of unirradiated (U) and irradiated (IR) cultures at fourth passage (4p) 48 hrs after
irradiation, or at fifth passage (5p) four to six weeks after irradiation. (C) Representative images of 5p plates stained with crystal violet illustrate
the presence of larger and more frequent patches of actively growing cells in cultures derived from irradiated vs. unirradiated cells.
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Figure 2 Cultures derived from irradiated human mammary epithelial cells show more SA-bgal (-) and p16 (-) cells than those derived
from unirradiated human mammary epithelial cells. Representative fields are shown stained for (A) SA-bgal activity (blue reaction product)
or (C) total p16 protein (green immunofluorescence). In (C), cell nuclei were counterstained with DAPI (blue). Inset = minus 1°Ab control. Note
the greater presence of SA-bgal (-) and p16 (-) cells in the irradiated cultures. In (B) and (D), cytometry was used to quantitatively compare the
percentages of positively and negatively staining cells in the corresponding cultures. In (B), flow cytometry results of an experiment performed
using B1450 cultures are summarized in a mean ± SE scatter plot (P < 0.001, non-parametric Wilcoxon test). In (D), the percentages of p16 (-)
cells in unirradiated and irradiated B1400 and B1450 cultures were determined using a Cellomics Array Scan VTI automated fluorescence
microscopic imaging system. For each condition, staining was measured for 460 fields per well and summarized in a mean ± SE scatter plot (P <
0.0001, non-parametric Wilcoxon test).
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deoxycytidine induced the expression of p16 protein to
a similar extent in virtually all cells derived from either
unirradiated or irradiated cultures (Figure 3A and Figure
3B, lower panels), indicating that the increased out-
growth of vHMEC in irradiated cultures was due to
reversible epigenetic silencing rather than to irreversible
radiation-induced mutations.
To determine whether radiation resulted in qualitative
and/or quantitative differences in the methylation of
CpG sites in the p16 promoter, we used bisulfite
sequencing to investigate the methylation status of 35
CpG sites spanning from -159 to +233, relative to the
translation start site (+1), in the core CpG island region
of the p16 gene in two specimens, B1450 and B1400,
with and without irradiation (Figure 3C). The majority
of the CpG sites were unmethylated in pre-stasis 3p
HMEC cultures harvested prior to stasis, whereas p16
promoter methylation was significantly increased in
both unirradiated and irradiated vHMEC cultures, as
indicated by the % methylation of individual CpG sites
(Figure 3D). The methylation patterns were qualitatively
and quantitatively distinct in irradiated and unirradiated
cultures, however there was no discernable quantitative
or qualitative correlation among p16 promoter methyla-
tion and passage level or radiation exposure status.
Radiation of different doses and qualities promotes
outgrowth of vHMEC
To determine the dose dependence of the radiation-
induced effect, replicate cultures from a single specimen
(B1450) were exposed to X-ray doses of 0, 5, 25, 50, 100
and 200 cGy and progeny cultures were analyzed for
SA-bgal activity four to six weeks following irradiation.
Ten replicates were used for each treatment group, and
the results for each treatment group were normalized to
mean of an unirradiated group (Figure 4A). Cultures
exposed to the highest doses (100 and 200 cGy) showed
significant differences compared to unirradiated cultures
(P < 0.0001; Wilcoxon/Kruskal-Wallis test). Cultures
exposed to lower doses (5 and 25 cGy) showed similar
trends, but the differences did not reach statistical sig-
nificance. In addition, no significant linear correlation
was observed between exposure dose and SA-bgal activ-
ity in the irradiated samples themselves, indicating the
absence of a detectable dose-dependence in the dose
range examined.
Densely ionizing
56Fe ions have been reported to be
more potent inducers of genomic instability, cell trans-
formation, and tumorigenesis than sparsely ionizing X-
rays. The relative biological effectiveness (RBE) for cell
killing of 1 GeV/amu
56Fe particles compared to X-rays
was 1.80 at D10 (dose resulting in 10% survival by cell
killing data) for HMEC [26]. RBE values reported for
other endpoints such as tumorigenesis in mice have
been much higher [27,28]. We investigated the effect of
radiation quality on the outgrowth of vHMEC. The pro-
geny of cells generated from three breast tissue speci-
mens (B1450, B1400, N17) were irradiated with densely
ionizing 1 GeV/amu
56Fe particles and compared to
those irradiated with sparsely ionizing
137Cs g-rays four
to six weeks after exposure, using flow cytometry to
measure SA-bgal activity and BrdU incorporation (Fig-
ure 4B and 4C) in 5 to 10 replicates from each specimen
for each treatment. Although the response of individual
specimens to radiation exposure varied, as expected, the
cultures irradiated with
137Cs g-rays contained signifi-
cantly more SA-bgal (-) and BrdU (+) cells, as in the X-
ray experiments, than unirradiated controls (P < 0.0001;
Wilcoxon test). Notably, the responses to 1 GeV/amu
56Fe ions were comparable to those of g-rays and were
not dose dependent.
Agent-based modeling can be used to accurately
simulate HMEC growth kinetics
We considered two possible explanations for our obser-
vations that radiation promoted vHMEC outgrowth;
first that radiation induced additional vHMEC and sec-
ond, that radiation accelerated the selection of pre-exist-
ing vHMEC, consistent with studies by Holst et al. [29]
demonstrating their existence in human breast tissues.
To evaluate the likelihood of these alternative mechan-
isms, we defined underlying assumptions to use an
agent-based model (ABM) to simulate vHMEC
outgrowth.
ABMs are computer simulations that represent sys-
tems as collections of autonomous decision-making
entities called agents [30]. Each agent is programmed to
respond to situations using a set of contextual rules.
These models are non-deterministic, are typically based
on multiple simulations so that a range of behaviors can
be established for a population, and have proven to be
very useful in predicting emerging properties from com-
plex systems [31-36]. Recently, ABMs have been used to
predict the responses of cancer stem cell populations to
ionizing radiation [37].
Based on experimental observations, we knew that the
growth of HMEC is contact inhibited, that the area
occupied by individual cells is reduced with increasing
culture density, that all HMEC have limited replication
capacity, that after a limited number of divisions most
HMEC are capable of expressing p16 that initiates
senescence, and that senescent cells do not readily
replate following trypsinization. Thus we defined the fol-
lowing agent rules: 1) agents replicate as long as there is
space surrounding them; 2) if there is no open space,
agents can still replicate as smaller entities until reach-
ing a minimum size; 3) when agents reach the
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Page 7 of 15Figure 3 The p16 gene is silenced epigenetically in both unirradiated and irradiated human mammary epithelial cells. (A) Immunoblot
analysis shows that p16 protein expression is very low in the eighth passage (8p) variant human mammary epithelial cells (vHMEC) cultures
derived from both unirradiated and irradiated cells, but that it is readily induced to similar extents in both cultures treated with 5-aza-
deoxycytidine (Aza). Lysates of HMEC undergoing stasis and MCF-7 cells were used as positive and negative controls, respectively. (B) p16
immunohistochemistry indicates that 8p vHMEC cultures derived from both unirradiated and irradiated cells contain primarily p16(-) cells, and
that p16 protein can be induced in virtually all cells in both cultures by 72 hr treatment with 3.3 μM 5-aza-deoxycytidine. (C) DNA sequence of
the CpG island region and a map of the -159 to +233 region of the p16 gene indicate the 35 CpG sites (CG or vertical lines) analyzed for
methylation status, and their positions relative to the translational start site (ATG) and exon 1a. Primers used for PCR amplification are
underlined. (D) The percent methylation of specific CpG sites (indicated by degree of shading) in the -159 to +233 region of the p16 gene was
determined by sequencing of individual bisulfite-treated DNAs obtained from the indicated pre-stasis HMEC and vHMEC cultures from
specimens B1450 and B1400.
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Figure 4 Radiation of different doses and qualities promotes outgrowth of variant human mammary epithelial cells. (A) Human
mammary epithelial cells (HMEC) cultures (10 or more replicates per dose) from specimen B1450 were subjected to X-ray doses between 5 and
200 cGy. Each treatment group was normalized to a control group and the resulting means ± SE were plotted versus dose. (B and C) When
assayed four to six weeks after irradiation with indicated doses (cGy) of
56Fe or g-rays, indicated HMEC cultures showed statistically significant
differences (P < 0.0001, non-parametric Wilcoxon test) in the percentages of (B) SA-bgal (-) and (C) BrdU (+) cells compared to control cultures.
Scatter plots indicate the mean ± SE of between 5 and 10 independent replicates for three individual specimens assayed for each treatment.
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Page 9 of 15maximum number of replications allowed, they stop
dividing and their type changes permanently to a senes-
cent type; 4) senescent agents do not reattach after
detachment during subculture.
To validate these rules, we first collected experimental
data describing growth characteristics of co-cultured
HMEC and vHMEC imaged by time-lapse microscopy
(note: vHMEC were obtained by taking HMEC that had
escaped stasis in a previous experiment). A representa-
tive series of time-lapse images shown in Figure 5A
illustrates how vHMEC outgrew labeled HMEC over
time, as vHMEC could not express p16 and thus would
not undergo stasis. Figure 5B shows the means and
standard deviations of population doublings measured
experimentally for each cell type in four replicate experi-
ments. Note that the HMEC used here were at a higher
passage than in Figure 1, as they rapidly underwent sta-
sis on Day 4 after having divided on average only three
times. In contrast, vHMEC cells grew until they reached
confluence. Thus, to simulatet h i ss e r i e so fc o - c u l t u r e
experiments, a maximum limit of three divisions for
HMEC agents was set, whereas no division limit for
vHMEC agents was set. As described above, Figure 5C
illustrates the key rule for contact inhibition, showing
how agents stop growing once they have reached a
minimum size determined experimentally by measuring
the average area of fully confluent cells. The corre-
sponding predictions from the ABM using these limited
assumptions correlated well with the experimental data
(Figure 5B), validating our rules.
Agent-based modeling was then used to simulate the
repetitive subculture experiments reported in Figure 1.
Based on the growth curves reported in Figure 1A (in
contrast to agents used in the validation step), a maxi-
mum of seven divisions for HMEC agents was set. We
assumed that vHMEC were present initially at low but
unknown frequencies in primary cultures and allowed a
maximum number of 40 divisions for vHMEC agents.
Using these assumptions and experimentally derived
parameters, simulations led to growth curves very simi-
lar to those observed in Figure 1A, with the same signif-
icant population doublings’ plateaus observed when the
majority of the cells entered stasis (that is, after seven
population doublings when assuming that 0.25% of
initial agents were vHMEC agents, as illustrated in Fig-
ure 6A and 6B). The plateau widths reflected the time
taken by vHMEC agents to overgrow the senescent
HMEC populations, and were inversely proportional to
the fraction of vHMEC agents present in the initial
populations; a relationship that could be fitted accu-
rately by an inverse power function (Figure 6C). Assum-
ing that the population doublings’ plateau indicated the
period of selection of a minority of vHMEC present in
primary cultures, the model could then inform us of the
initial proportions of vHMEC in real specimens by
extrapolating the plateau widths measured in these spe-
cimens with the fit obtained in Figure 6C (that is, for
the three unirradiated cultures profiled in Figure 1A,
plateau durations of 23, 60, and 10 days corresponded
to initial vHMEC proportions of 0.25, 0.06, and 3.5%,
respectively). Anecdotally, we found that the initial per-
centage of vHMEC present in the primary culture
derived from a reduction mammoplasty specimen
(B1400) was similar to values found for reduction mam-
moplasties in an earlier report [29], but that the percen-
tages of vHMEC in primary cultures derived from
prophylactic mastectomies (B1450, B1389) were higher.
Data from additional specimens of each type will be
needed to determine whether this is a statistically signif-
icant correlation.
Agent-based modeling predicts the accelerated
outgrowth of the progeny of irradiated HMEC
Ionizing radiation is known to induce senescence in a
variety of cell types, however susceptibility to radiation-
induced senescence may vary with cell type. Therefore,
to model the response of HMEC agents to ionizing
radiation, we first had to experimentally measure the
relative susceptibilities to radiation-induced senescence
of pre-stasis (HMEC) and post-stasis (vHMEC) cells
from the same individual. Measurement of SA-bgal
levels indicated that normal HMEC were more likely to
undergo senescence after the same dose of ionizing
radiation than vHMEC; 6 Gy or more induced more
than 90% SA-bgal (+) pre-stasis cells while even 10 Gy
induced less than 20% SA-bgal (+) post-stasis cells (Fig-
u r e7 B ) .F o l l o w i n g2G yo fX - r a y s ,t h er e l a t i v en u m b e r
of SA-bgal (+) cells increased more than 40% in pre-sta-
sis populations, but less than 5% in post-stasis popula-
tions. The radiation-induced senescence parameters for
each agent type were added to the ABM, and simula-
tions were repeated. As illustrated in Figure 7A, the pre-
sence of senescent agents immediately in the first
passage led to an earlier selection of vHMEC agents,
and the preferential senescence of HMEC agents led to
a proliferative advantage of vHMEC agents. Accordingly,
the ABM kinetics predicted a shorter growth plateau
after exposure to 2 Gy (Figure 7C), matching experi-
mental observations.
Discussion
A major challenge is to understand how cellular
responses to radiation are integrated in a multicellular
context to affect human health. In this study, we show
how radiation can promote the outgrowth of pre-malig-
nant cells by accelerating senescence of normal cells.
We used ABM to show that the rapidity with which
radiation-resistant vHMEC selectively populate cultures
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Page 10 of 15Figure 5 The agent-based model is validated by experimental data.( A) Growth characteristics of co-cultured human mammary epithelial
cells (HMEC) (labeled with vital dye Qtracker565; Invitrogen) and variant human mammary epithelial cells (vHMEC) (unlabeled) were recorded by
time-lapse microscopy. An example is presented of the changes in proportions of cells present in a field of view monitored over seven days. (B)
Growth of co-cultured HMEC and vHMEC was compared with ABM simulations. Each data point represents the mean of four biological
replicates. Pre-stasis HMEC (red diamonds) stopped proliferating after four days in culture in contrast to vHMEC (green triangles) that continued
to proliferate until the cultures achieved confluence. Solid lines show agent-based simulations, based on the initial cell densities, cell cycle
duration during the proliferative phase (26 hours for both cell types), maximum cell compression observed at full confluence, and an intrinsic
limit on the number of population doublings achievable by HMEC. Note that the simulations of the model were well correlated with the
experimental data, indicating that kinetic growth rates could be predicted accurately for both cell types using a limited number of assumptions.
(C) Illustration of growth simulation. Normal growing HMEC (red) undergo limited divisions before losing proliferative potential and undergoing
stasis (blue). vHMEC (green) are capable of unlimited of divisions in this example. At low density (Day 1), most cells occupy a maximum area
(that is, 21 pixels equivalent to 175 μm
2, matching light microscopy measurements). Cells continue dividing as space becomes more restricted
(Day 5), until the available adjacent space reaches a minimum of six pixels (50 μm
2 at Day 14). Such simulations accurately recapitulate contact
inhibition as measured by time-lapse microscopy.
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Page 11 of 15can be predicted by the initial proportion of the vHMEC
present in primary cultures, the differential rate at which
sensitive HMEC succumb to radiation-induced loss of
growth potential, and the physical space available for
expansion.
Together with p53, the p16 protein functions as a sen-
tinel that integrates various cellular signals and stresses
to limit proliferation. Methylation of the p16 gene has
been identified in situ in histologically normal mammary
epithelial cells of disease-free women [29]. A Luria-Del-
brück fluctuation analysis suggests that such cells may
be the source of vHMEC that continue to proliferate
after most HMEC in long term cultures have undergone
p16-associated stasis [29]. Expression of p16 appears to
be strongly selected against in many human solid
tumors, including those of the breast, where the gene
encoding p16 is deleted in approximately 20% [38] and
inactivated epigenetically in an additional 20% [39] of
cases. Interestingly, exposure of workers in nuclear
weapons manufacturing facilities to plutonium, for
example, has been strongly linked (P = 0.03) to methyla-
tion of the p16 gene in lung adenocarcinomas [40].
Renal cell carcinomas from patients living in areas
contaminated by the Chernobyl accident have also
shown aberrant hypermethylation of the p16/p14 locus
[41].
As we and others have observed, radiation itself does
not appear to be a direct inducer of p16 (Additional file
1). Our new results indicate that radiation-induced
stress can be integrated with p16-inducing factors that
cause premature growth arrest and senescence. ABM
simulations showed that radiation can advance the
selection process, allowing vHMEC to overtake and fill
the voids created by the prematurely senescing normal
cells. A similar model, in which lesion growth is driven
by opportunistic expansion of apoptosis-resistant p53
mutant cells, has recently been proposed for UVB-
induced squamous cell carcinomas [42]. The expansion
of such a variant population in situ would be expected
to expand the target size in which additional malignancy
promoting aberrations could occur, especially since this
population has been shown to be particularly susceptible
to genomic instability caused by telomere dysfunction
and centrosome irregularities [6,13,14].
While accurately modeling the accelerated outgrowth
of vHMEC from irradiated cultures, the current ABM
Figure 6 Growth and senescence of heterogeneous human mammary epithelial cells cultures can be accurately modeled using the
agent-based model.( A and B) In a model extending over several passages, cells are initially plated at 20% confluence and replated when the
populations reach 80% confluence. By Passage 3, most human mammary epithelial cells (HMEC) have undergone seven divisions, and enter
stasis. As a result, the time to confluence is extended, and a population doubling plateau is observed. Ultimately, the variant human mammary
epithelial cells (vHMEC) take up the available area, and exponential growth resumes. (C) Changing the initial density of vHMEC leads to variable
plateau periods. This dependence is fitted by a power function that allows the calculation of the initial density of vHMEC present in the primary
culture based on plateau length. The results of individual simulations are plotted as points.
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Page 12 of 15does not explain why, in some cases, the total number
of population doublings achieved by vHMEC from irra-
diated cultures exceeded that of vHMEC from unirra-
diated controls. This outcome could be due to either a
radiation-induced increase in the number of vHMEC or
modification of the phenotype of the existing vHMEC.
Since the phenotypic feature of the vHMEC that allows
them to avoid or overcome stasis is the stable repression
of p16 expression, one possibility is that radiation
directly affects epigenetic process(es) involved in the
initiation or maintenance of this repression. DNA
methylation-associated silencing of mammalian genes
has been proposed to be a process, during which
instances of spontaneous gene reactivation are initially
frequent, becoming progressively less frequent over the
course of multiple cell divisions [43,44]. In agreement
with this hypothesis, recent experiments indicate that
p16 gene methylation occurs progressively in clonal
vHMEC populations after silencing has occurred [45].
Irradiation may lead to acceleration of this process and
thus reduce the frequency of spontaneous p16 reactiva-
tion. Indeed, while occasional p16(+) cells could be
observed in 8p post-stasis cultures, they were more fre-
quent in the progeny of unirradiated versus irradiated
cultures (data not shown). The mechanism responsible
for this difference remains to be discovered, but may
involve radiation effects on sentinel proteins such as
p53. Notably, radiation has been reported to relieve
p53-mediated repression of DNA methyltransferase 1
(Dnmt1) in human colon carcinoma cells [46]. Under
certain circumstances, Dnmt1, which has been shown to
be continually required for p16 repression [47], will cat-
alyze de novo methylation of specific promoter CpG
islands [48]. Thus, radiation, acting through transient
activation of p53, could cause de novo methylation and
more stable silencing of the p16 gene.
Conclusions
We have found that radiation can indirectly promote the
outgrowth of a putative pre-malignant breast cell
Figure 7 Differential sensitivity to radiation-induced senescence and loss of growth leads to increased outgrowth of p16(-) human
mammary epithelial cells during stasis. (A) Time snapshots of one representative simulation of sequential subcultures executed using the
same initial conditions as in Figure 6A, but including prematurely senescent human mammary epithelial cells (HMEC) agents (labeled blue)
induced by exposure to 2 Gy of X-rays. Note the earlier and more robust outgrowth of vHMEC agents (labeled green) in this simulation versus
the simulation shown in Figure 6A. (B) Growing pre- and post-stasis HMEC from the same individual were exposed to the indicated doses of X-
rays, then stained and evaluated for SA-bgal expression. The resulting data were then normalized to the percentage of SA-bgal(-) HMEC in the
respective unirradiated populations. Fitted curves were of the form (e
(-a.D)) where D is the dose and a the fitted coefficient; R
2 values were >0.96
in both cases. These fitted curves were used to model radiation-induced senescence in the simulation depicted in (A). (C) Agent-based
modeling was used to simulate the growth kinetics of HMEC cultures exposed to 0 or 2 Gy of X-rays. Data ± SE for five independent simulations
for each condition are plotted. Note that the model predicts a shorter growth plateau in the irradiated sample, in accord with experimental
observations.
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Page 13 of 15population by accelerating senescence of normal breast
cells. Differential sensitivity of these cell populations to
radiation-induced senescence has not previously been
demonstrated. While the mechanism responsible for this
differential sensitivity is beyond the scope of our present
investigation, the work advances a systems-based para-
digm of carcinogenic activity by a prototypic genotoxic
agent, ionizing radiation. The ABM simulation of well-
described HMEC phenotypes in primary cultures helped
to distinguish between induced vHMEC and altered
population kinetics as plausible explanations for the
observed response to radiation. ABM showed that differ-
ential sensitivity to radiation-induced senescence can at
least partly explain the enhanced outgrowth of vHMEC
from irradiated cultures. This simple in vitro system
illustrates the concept that heterogeneous responses of
individual cells within a population must be integrated
to achieve a system-level understanding of radiation
effects.
Additional file 1: Supplementary Figure S1 - X-irradiation does not
induce p16 directly. p16 immunohistochemistry indicates that 3p HMEC
cultures derived from specimen N17 did not express detectable p16
protein 24 hrs after irradiation with 2 Gy X-rays. Indicated negative and
positive controls for specific antibody-dependent staining are shown in
left panels.
Click here for file
[http://www.biomedcentral.com/content/supplementary/bcr2477-S1.pdf]
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